APA
Pellegrin M., Szostak J., Bouzourène K., Aubert J., Berthelot A., Nussberger J., Laurant P. & Mazzolai L. (2017). Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.
Chicago
Pellegrin Maxime, Szostak Justyna, Bouzourène Karima, Aubert Jean-François, Berthelot Alain, Nussberger Jürg, Laurant Pascal and Mazzolai Lucia. 2017. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.
Harvard
Pellegrin M., Szostak J., Bouzourène K., Aubert J., Berthelot A., Nussberger J., Laurant P. and Mazzolai L. (2017). Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.
MLA
Pellegrin Maxime, Szostak Justyna, Bouzourène Karima, Aubert Jean-François, Berthelot Alain, Nussberger Jürg, Laurant Pascal and Mazzolai Lucia. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics. 2017.